secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001640334-25-000087
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria shareholders re-elect all directors; McKechnie gets 54% support, Baxter 62%
--------------------------------------------------------------------------------

- Annual meeting on Jan 14, 2025: 9,761,279 shares (55.93% of outstanding) represented.
- Directors elected: Bunka 89%, Docherty 98%, Baxter 62%, McKechnie 54%, Reese 90%, Christopher 98%, Bhullar 98%.
- Say-on-pay frequency approved every three years with 66% of votes cast; advisory compensation passed at 97%.
- Warrant exercise proposal approved by 70% of votes cast; auditor Malone Bailey LLP ratified with 98%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/0001640334-25-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer